A/Prof Peter Foley
Associate Professor
Department of Medicine
373 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial.
DOI: 10.1093/bjd/ljag1092026
Journal article
Real-World Efficacy and Drug Survival of Adalimumab in Australian Patients With Psoriasis
DOI: 10.1111/ajd.700242026
Journal article
Topical therapies for psoriasis Selection, education, escalation of therapy
2026
Journal article
Long-Term Upadacitinib Safety in Moderate-to-Severe Atopic Dermatitis up to 7 Years: An Integrated Analysis With Over 9600 Patient-Years of Exposure
DOI: 10.25251/evafb1452026
Journal article
Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies
DOI: 10.1111/ajd.700022026
Journal article
Waiting for Access: How Bureaucracy Blocks Innovation in Australian Dermatology
DOI: 10.1111/ajd.700302019
Research Contracts
Salary Contribution - Ci Peter Foley 19/20 - Skin & Cancer Foundation Inc
RECENT SCHOLARLY WORKS
2026
Journal article
Is the Future Oral? Towards Sustainable and Patient-Centered Biologic Treatment in Dermatology
DOI: 10.1111/ajd.146232026
Journal article
Melanoma Current perspectives on diagnosis and management
2026
Journal article
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study
DOI: 10.1111/jdv.703132026
Journal article
Closing the Gap in Photoprotection: Implications for Skin of Colour in Australia
DOI: 10.1111/ajd.70054